Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive-enhancing DA Medications for Cocaine Dependence
NCT01393457Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Jun 2011
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropinirole, levodopa + carbidopa in cocaine dependence, sponsored by UTHealth Houston. Started Jun 2011; status: completed.
02
Drugs
ropinirolelevodopa + carbidopa
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT01393457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393457.